United States B-Cell Inhibitor Market Report 2017

September 2017 | 100 pages | ID: U045BBE317EEN
QYResearch

Abstracts

In this report, the United States B-Cell Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of B-Cell Inhibitor in these regions, from 2012 to 2022 (forecast).

United States B-Cell Inhibitor market competition by top manufacturers/players, with B-Cell Inhibitor sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Abbvie
• Eli Lilly
• Bristol-Myers Squibb
• Celgene
• Celltrion
• Merck

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Abatacept
• Rituximab
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of B-Cell Inhibitor for each application, including

• Medical Care
• Experiment
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States B-Cell Inhibitor Market Report 2017

1 B-CELL INHIBITOR OVERVIEW

1.1 Product Overview and Scope of B-Cell Inhibitor
1.2 Classification of B-Cell Inhibitor by Product Category
  1.2.1 United States B-Cell Inhibitor Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States B-Cell Inhibitor Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Abatacept
  1.2.4 Rituximab
  1.2.5 Others
1.3 United States B-Cell Inhibitor Market by Application/End Users
  1.3.1 United States B-Cell Inhibitor Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Medical Care
  1.3.3 Experiment
  1.3.4 Others
1.4 United States B-Cell Inhibitor Market by Region
  1.4.1 United States B-Cell Inhibitor Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West B-Cell Inhibitor Status and Prospect (2012-2022)
  1.4.3 Southwest B-Cell Inhibitor Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic B-Cell Inhibitor Status and Prospect (2012-2022)
  1.4.5 New England B-Cell Inhibitor Status and Prospect (2012-2022)
  1.4.6 The South B-Cell Inhibitor Status and Prospect (2012-2022)
  1.4.7 The Midwest B-Cell Inhibitor Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of B-Cell Inhibitor (2012-2022)
  1.5.1 United States B-Cell Inhibitor Sales and Growth Rate (2012-2022)
  1.5.2 United States B-Cell Inhibitor Revenue and Growth Rate (2012-2022)

2 UNITED STATES B-CELL INHIBITOR MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States B-Cell Inhibitor Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States B-Cell Inhibitor Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States B-Cell Inhibitor Average Price by Players/Suppliers (2012-2017)
2.4 United States B-Cell Inhibitor Market Competitive Situation and Trends
  2.4.1 United States B-Cell Inhibitor Market Concentration Rate
  2.4.2 United States B-Cell Inhibitor Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers B-Cell Inhibitor Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES B-CELL INHIBITOR SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States B-Cell Inhibitor Sales and Market Share by Region (2012-2017)
3.2 United States B-Cell Inhibitor Revenue and Market Share by Region (2012-2017)
3.3 United States B-Cell Inhibitor Price by Region (2012-2017)

4 UNITED STATES B-CELL INHIBITOR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States B-Cell Inhibitor Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States B-Cell Inhibitor Revenue and Market Share by Type (2012-2017)
4.3 United States B-Cell Inhibitor Price by Type (2012-2017)
4.4 United States B-Cell Inhibitor Sales Growth Rate by Type (2012-2017)

5 UNITED STATES B-CELL INHIBITOR SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States B-Cell Inhibitor Sales and Market Share by Application (2012-2017)
5.2 United States B-Cell Inhibitor Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES B-CELL INHIBITOR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Abbvie
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 B-Cell Inhibitor Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abbvie B-Cell Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Eli Lilly
  6.2.2 B-Cell Inhibitor Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Eli Lilly B-Cell Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bristol-Myers Squibb
  6.3.2 B-Cell Inhibitor Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bristol-Myers Squibb B-Cell Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Celgene
  6.4.2 B-Cell Inhibitor Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Celgene B-Cell Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Celltrion
  6.5.2 B-Cell Inhibitor Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Celltrion B-Cell Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Merck
  6.6.2 B-Cell Inhibitor Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Merck B-Cell Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview

7 B-CELL INHIBITOR MANUFACTURING COST ANALYSIS

7.1 B-Cell Inhibitor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of B-Cell Inhibitor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 B-Cell Inhibitor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of B-Cell Inhibitor Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES B-CELL INHIBITOR MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States B-Cell Inhibitor Sales Volume, Revenue Forecast (2017-2022)
11.2 United States B-Cell Inhibitor Sales Volume Forecast by Type (2017-2022)
11.3 United States B-Cell Inhibitor Sales Volume Forecast by Application (2017-2022)
11.4 United States B-Cell Inhibitor Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of B-Cell Inhibitor
Figure United States B-Cell Inhibitor Market Size (USD/Pcs) by Type (2012-2022)
Figure United States B-Cell Inhibitor Sales Volume Market Share by Type (Product Category) in 2016
Figure Abatacept Product Picture
Figure Rituximab Product Picture
Figure Others Product Picture
Figure United States B-Cell Inhibitor Market Size (USD/Pcs) by Application (2012-2022)
Figure United States Sales Market Share of B-Cell Inhibitor by Application in 2016
Figure Medical Care Examples
Table Key Downstream Customer in Medical Care
Figure Experiment Examples
Table Key Downstream Customer in Experiment
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States B-Cell Inhibitor Market Size (Million USD) by Region (2012-2022)
Figure The West B-Cell Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest B-Cell Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic B-Cell Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England B-Cell Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US B-Cell Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest B-Cell Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States B-Cell Inhibitor Sales (USD/Pcs) and Growth Rate (2012-2022)
Figure United States B-Cell Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States B-Cell Inhibitor Market Major Players Product Sales Volume (USD/Pcs) (2012-2017)
Table United States B-Cell Inhibitor Sales (USD/Pcs) of Key Players/Suppliers (2012-2017)
Table United States B-Cell Inhibitor Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States B-Cell Inhibitor Sales Share by Players/Suppliers
Figure 2017 United States B-Cell Inhibitor Sales Share by Players/Suppliers
Figure United States B-Cell Inhibitor Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States B-Cell Inhibitor Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States B-Cell Inhibitor Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States B-Cell Inhibitor Revenue Share by Players/Suppliers
Figure 2017 United States B-Cell Inhibitor Revenue Share by Players/Suppliers
Table United States Market B-Cell Inhibitor Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market B-Cell Inhibitor Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States B-Cell Inhibitor Market Share of Top 3 Players/Suppliers
Figure United States B-Cell Inhibitor Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers B-Cell Inhibitor Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers B-Cell Inhibitor Product Category
Table United States B-Cell Inhibitor Sales (USD/Pcs) by Region (2012-2017)
Table United States B-Cell Inhibitor Sales Share by Region (2012-2017)
Figure United States B-Cell Inhibitor Sales Share by Region (2012-2017)
Figure United States B-Cell Inhibitor Sales Market Share by Region in 2016
Table United States B-Cell Inhibitor Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States B-Cell Inhibitor Revenue Share by Region (2012-2017)
Figure United States B-Cell Inhibitor Revenue Market Share by Region (2012-2017)
Figure United States B-Cell Inhibitor Revenue Market Share by Region in 2016
Table United States B-Cell Inhibitor Price (USD/Unit) by Region (2012-2017)
Table United States B-Cell Inhibitor Sales (USD/Pcs) by Type (2012-2017)
Table United States B-Cell Inhibitor Sales Share by Type (2012-2017)
Figure United States B-Cell Inhibitor Sales Share by Type (2012-2017)
Figure United States B-Cell Inhibitor Sales Market Share by Type in 2016
Table United States B-Cell Inhibitor Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States B-Cell Inhibitor Revenue Share by Type (2012-2017)
Figure Revenue Market Share of B-Cell Inhibitor by Type (2012-2017)
Figure Revenue Market Share of B-Cell Inhibitor by Type in 2016
Table United States B-Cell Inhibitor Price (USD/Unit) by Types (2012-2017)
Figure United States B-Cell Inhibitor Sales Growth Rate by Type (2012-2017)
Table United States B-Cell Inhibitor Sales (USD/Pcs) by Application (2012-2017)
Table United States B-Cell Inhibitor Sales Market Share by Application (2012-2017)
Figure United States B-Cell Inhibitor Sales Market Share by Application (2012-2017)
Figure United States B-Cell Inhibitor Sales Market Share by Application in 2016
Table United States B-Cell Inhibitor Sales Growth Rate by Application (2012-2017)
Figure United States B-Cell Inhibitor Sales Growth Rate by Application (2012-2017)
Table Abbvie Basic Information List
Table Abbvie B-Cell Inhibitor Sales (USD/Pcs), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbvie B-Cell Inhibitor Sales Growth Rate (2012-2017)
Figure Abbvie B-Cell Inhibitor Sales Market Share in United States (2012-2017)
Figure Abbvie B-Cell Inhibitor Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly B-Cell Inhibitor Sales (USD/Pcs), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly B-Cell Inhibitor Sales Growth Rate (2012-2017)
Figure Eli Lilly B-Cell Inhibitor Sales Market Share in United States (2012-2017)
Figure Eli Lilly B-Cell Inhibitor Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb B-Cell Inhibitor Sales (USD/Pcs), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb B-Cell Inhibitor Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb B-Cell Inhibitor Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb B-Cell Inhibitor Revenue Market Share in United States (2012-2017)
Table Celgene Basic Information List
Table Celgene B-Cell Inhibitor Sales (USD/Pcs), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celgene B-Cell Inhibitor Sales Growth Rate (2012-2017)
Figure Celgene B-Cell Inhibitor Sales Market Share in United States (2012-2017)
Figure Celgene B-Cell Inhibitor Revenue Market Share in United States (2012-2017)
Table Celltrion Basic Information List
Table Celltrion B-Cell Inhibitor Sales (USD/Pcs), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celltrion B-Cell Inhibitor Sales Growth Rate (2012-2017)
Figure Celltrion B-Cell Inhibitor Sales Market Share in United States (2012-2017)
Figure Celltrion B-Cell Inhibitor Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck B-Cell Inhibitor Sales (USD/Pcs), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck B-Cell Inhibitor Sales Growth Rate (2012-2017)
Figure Merck B-Cell Inhibitor Sales Market Share in United States (2012-2017)
Figure Merck B-Cell Inhibitor Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of B-Cell Inhibitor
Figure Manufacturing Process Analysis of B-Cell Inhibitor
Figure B-Cell Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of B-Cell Inhibitor Major Players/Suppliers in 2016
Table Major Buyers of B-Cell Inhibitor
Table Distributors/Traders List
Figure United States B-Cell Inhibitor Sales Volume (USD/Pcs) and Growth Rate Forecast (2017-2022)
Figure United States B-Cell Inhibitor Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States B-Cell Inhibitor Price (USD/Unit) Trend Forecast (2017-2022)
Table United States B-Cell Inhibitor Sales Volume (USD/Pcs) Forecast by Type (2017-2022)
Figure United States B-Cell Inhibitor Sales Volume (USD/Pcs) Forecast by Type (2017-2022)
Figure United States B-Cell Inhibitor Sales Volume (USD/Pcs) Forecast by Type in 2022
Table United States B-Cell Inhibitor Sales Volume (USD/Pcs) Forecast by Application (2017-2022)
Figure United States B-Cell Inhibitor Sales Volume (USD/Pcs) Forecast by Application (2017-2022)
Figure United States B-Cell Inhibitor Sales Volume (USD/Pcs) Forecast by Application in 2022
Table United States B-Cell Inhibitor Sales Volume (USD/Pcs) Forecast by Region (2017-2022)
Table United States B-Cell Inhibitor Sales Volume Share Forecast by Region (2017-2022)
Figure United States B-Cell Inhibitor Sales Volume Share Forecast by Region (2017-2022)
Figure United States B-Cell Inhibitor Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources